• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

共享最近邻方法和交互式浏览器用于全面非小细胞肺癌数据集的网络分析。

Shared Nearest Neighbors Approach and Interactive Browser for Network Analysis of a Comprehensive Non-Small-Cell Lung Cancer Data Set.

机构信息

TRACTION Platform, Division of Therapeutics Discovery, The University of Texas MD Anderson Cancer Center, Houston, TX.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

出版信息

JCO Clin Cancer Inform. 2022 Jul;6:e2200040. doi: 10.1200/CCI.22.00040.

DOI:10.1200/CCI.22.00040
PMID:35944232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9470146/
Abstract

PURPOSE

Advances in biological measurement technologies are enabling large-scale studies of patient cohorts across multiple omics platforms. Holistic analysis of these data can generate actionable insights for translational research and necessitate new approaches for data integration and mining.

METHODS

We present a novel approach for integrating data across platforms on the basis of the shared nearest neighbors algorithm and use it to create a network of multiplatform data from the immunogenomic profiling of non-small-cell lung cancer project.

RESULTS

Benchmarking demonstrates that the shared nearest neighbors-based network approach outperforms a traditional gene-gene network in capturing established interactions while providing new ones on the basis of the interplay between measurements from different platforms. When used to examine patient characteristics of interest, our approach provided signatures associated with and new leads related to recurrence and TP53 oncogenotype.

CONCLUSION

The network developed offers an unprecedented, holistic view into immunogenomic profiling of non-small-cell lung cancer, which can be explored through the accompanying interactive browser that we built.

摘要

目的

生物测量技术的进步使人们能够在多个组学平台上对患者队列进行大规模研究。对这些数据进行整体分析可为转化研究提供可操作的见解,并需要新的方法来进行数据集成和挖掘。

方法

我们提出了一种基于最近邻共享算法的跨平台数据集成新方法,并将其用于创建非小细胞肺癌免疫基因组分析项目的多平台数据网络。

结果

基准测试表明,基于最近邻共享的网络方法在捕获已建立的相互作用方面优于传统的基因-基因网络,同时基于不同平台的测量值之间的相互作用提供了新的相互作用。当用于检查感兴趣的患者特征时,我们的方法提供了与复发和 TP53 癌基因型相关的特征以及新的线索。

结论

所开发的网络提供了对非小细胞肺癌免疫基因组分析的前所未有的整体视图,可以通过我们构建的配套交互浏览器进行探索。

相似文献

1
Shared Nearest Neighbors Approach and Interactive Browser for Network Analysis of a Comprehensive Non-Small-Cell Lung Cancer Data Set.共享最近邻方法和交互式浏览器用于全面非小细胞肺癌数据集的网络分析。
JCO Clin Cancer Inform. 2022 Jul;6:e2200040. doi: 10.1200/CCI.22.00040.
2
Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation.非小细胞肺癌的生物标志物发现:整合基因表达谱分析、荟萃分析和组织微阵列验证。
Clin Cancer Res. 2013 Jan 1;19(1):194-204. doi: 10.1158/1078-0432.CCR-12-1139. Epub 2012 Oct 2.
3
Unsupervised detection of genes of influence in lung cancer using biological networks.基于生物网络的肺癌影响基因无监督检测。
Bioinformatics. 2011 Nov 15;27(22):3166-72. doi: 10.1093/bioinformatics/btr533. Epub 2011 Sep 28.
4
Multiplatform-based molecular subtypes of non-small-cell lung cancer.基于多平台的非小细胞肺癌分子亚型
Oncogene. 2017 Mar;36(10):1384-1393. doi: 10.1038/onc.2016.303. Epub 2016 Oct 24.
5
Gene profiling of clinical routine biopsies and prediction of survival in non-small cell lung cancer.临床常规活检的基因谱分析与非小细胞肺癌生存预测。
Am J Respir Crit Care Med. 2010 Jan 15;181(2):181-8. doi: 10.1164/rccm.200812-1807OC. Epub 2009 Oct 15.
6
Expression profiling of non-small cell lung carcinoma identifies metastatic genotypes based on lymph node tumor burden.基于淋巴结肿瘤负荷的非小细胞肺癌表达谱分析可识别转移基因型。
J Thorac Cardiovasc Surg. 2004 May;127(5):1332-41; discussion 1342. doi: 10.1016/j.jtcvs.2003.11.060.
7
Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer.共表达网络分析确定脾酪氨酸激酶(SYK)为小细胞肺癌一个亚群中的候选致癌驱动因子。
BMC Syst Biol. 2013;7 Suppl 5(Suppl 5):S1. doi: 10.1186/1752-0509-7-S5-S1. Epub 2013 Dec 9.
8
In silico comparative genomic analysis of two non-small cell lung cancer subtypes and their potentials for cancer classification.两种非小细胞肺癌亚型的计算机模拟比较基因组分析及其癌症分类潜力
Cancer Genomics Proteomics. 2014 Nov-Dec;11(6):303-10.
9
Microarray data re-annotation reveals specific lncRNAs and their potential functions in non-small cell lung cancer subtypes.微阵列数据重新注释揭示了非小细胞肺癌亚型中特定的长链非编码 RNA 及其潜在功能。
Mol Med Rep. 2017 Oct;16(4):5129-5136. doi: 10.3892/mmr.2017.7244. Epub 2017 Aug 14.
10
Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.通过综合生物信息学分析鉴定和验证非小细胞肺癌中具有预后价值的关键基因。
Thorac Cancer. 2020 Apr;11(4):851-866. doi: 10.1111/1759-7714.13298. Epub 2020 Feb 14.

引用本文的文献

1
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.CTLA4 阻断消除了 KEAP1/STK11 相关的对 PD-(L)1 抑制剂的耐药性。
Nature. 2024 Nov;635(8038):462-471. doi: 10.1038/s41586-024-07943-7. Epub 2024 Oct 9.
2
Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept.CT 合成 PET 提高肺癌诊断和预后:概念验证。
Cell Rep Med. 2024 Mar 19;5(3):101463. doi: 10.1016/j.xcrm.2024.101463. Epub 2024 Mar 11.
3
ATM Mutations Associate with Distinct Co-Mutational Patterns and Therapeutic Vulnerabilities in NSCLC.ATM 突变与 NSCLC 中独特的共突变模式和治疗弱点相关。
Clin Cancer Res. 2023 Dec 1;29(23):4958-4972. doi: 10.1158/1078-0432.CCR-23-1122.
4
Autotaxin suppresses cytotoxic T cells via LPAR5 to promote anti-PD-1 resistance in non-small cell lung cancer.自分泌酶通过 LPAR5 抑制细胞毒性 T 细胞,从而促进非小细胞肺癌对 PD-1 抑制剂的耐药性。
J Clin Invest. 2023 Sep 1;133(17):e163128. doi: 10.1172/JCI163128.
5
EMT activates exocytotic Rabs to coordinate invasion and immunosuppression in lung cancer.EMT 通过激活胞吐 Rabs 来协调肺癌的侵袭和免疫抑制。
Proc Natl Acad Sci U S A. 2023 Jul 11;120(28):e2220276120. doi: 10.1073/pnas.2220276120. Epub 2023 Jul 5.

本文引用的文献

1
PCIG: a web-based application to explore immune-genomics interactions across cancer types.PCIG:一个基于网络的应用程序,用于探索跨癌症类型的免疫基因组相互作用。
Bioinformatics. 2022 Apr 12;38(8):2374-2376. doi: 10.1093/bioinformatics/btac111.
2
Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US.美国非小细胞肺癌患者的发病率、患病率、生存率和初始治疗的更新。
JAMA Oncol. 2021 Dec 1;7(12):1824-1832. doi: 10.1001/jamaoncol.2021.4932.
3
Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer.不同的肿瘤浸润淋巴细胞图谱与局限性非小细胞肺癌的临床结局相关。
Ann Oncol. 2022 Jan;33(1):42-56. doi: 10.1016/j.annonc.2021.09.021. Epub 2021 Oct 13.
4
Neoadjuvant Chemotherapy Increases Cytotoxic T Cell, Tissue Resident Memory T Cell, and B Cell Infiltration in Resectable NSCLC.新辅助化疗增加可切除 NSCLC 中的细胞毒性 T 细胞、组织驻留记忆 T 细胞和 B 细胞浸润。
J Thorac Oncol. 2021 Jan;16(1):127-139. doi: 10.1016/j.jtho.2020.09.027. Epub 2020 Oct 21.
5
T-cell repertoire analysis and metrics of diversity and clonality.T 细胞受体库分析及多样性和克隆性指标。
Curr Opin Biotechnol. 2020 Oct;65:284-295. doi: 10.1016/j.copbio.2020.07.010. Epub 2020 Sep 2.
6
Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohort.中性粒细胞扩增定义了切除的非小细胞肺癌中具有免疫抑制作用的外周和肿瘤内炎症微环境:对一个前瞻性免疫分析队列的描述性分析。
J Immunother Cancer. 2020 Apr;8(1). doi: 10.1136/jitc-2019-000405.
7
Pan-cancer analysis of whole genomes.泛癌症全基因组分析。
Nature. 2020 Feb;578(7793):82-93. doi: 10.1038/s41586-020-1969-6. Epub 2020 Feb 5.
8
Comprehensive T cell repertoire characterization of non-small cell lung cancer.非小细胞肺癌的全面 T 细胞受体谱特征。
Nat Commun. 2020 Jan 30;11(1):603. doi: 10.1038/s41467-019-14273-0.
9
A network of human functional gene interactions from knockout fitness screens in cancer cells.人类功能基因相互作用网络来自癌细胞中的 knockout 适应度筛选。
Life Sci Alliance. 2019 Apr 12;2(2). doi: 10.26508/lsa.201800278. Print 2019 Apr.
10
Mutant p53 as a guardian of the cancer cell.突变型 p53 作为癌细胞的守护者。
Cell Death Differ. 2019 Jan;26(2):199-212. doi: 10.1038/s41418-018-0246-9. Epub 2018 Dec 11.